161 related articles for article (PubMed ID: 11768671)
1. Integrating behavioral and pharmacological interventions in treating clients with psychiatric disorders and mental retardation.
Sevin JA; Bowers-Stephens C; Hamilton ML; Ford A
Res Dev Disabil; 2001; 22(6):463-85. PubMed ID: 11768671
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacological issues in treating psychiatric disorders of patients with mental retardation.
Arnold LE
Ann Clin Psychiatry; 1993 Sep; 5(3):189-97. PubMed ID: 8281242
[TBL] [Abstract][Full Text] [Related]
3. Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior.
Tsiouris JA; Cohen IL; Patti PJ; Korosh WM
J Clin Psychiatry; 2003 Sep; 64(9):1081-90. PubMed ID: 14628984
[TBL] [Abstract][Full Text] [Related]
4. A behavioral diagnostic paradigm for integrating behavior-analytic and psychopharmacological interventions for people with a dual diagnosis.
Pyles DA; Muniz K; Cade A; Silva R
Res Dev Disabil; 1997; 18(3):185-214. PubMed ID: 9220544
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment considerations with comorbid developmentally disabled populations.
Fuller CG; Sabatino DA
J Clin Psychol; 1998 Jan; 54(1):1-10. PubMed ID: 9476703
[TBL] [Abstract][Full Text] [Related]
6. A review of behavioral and pharmacological treatments for habit disorders in individuals with mental retardation.
Long ES; Miltenberger RG
J Behav Ther Exp Psychiatry; 1998 Jun; 29(2):143-56. PubMed ID: 9762591
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
8. Psychopharmacology and applied behavioral analysis: tandem treatment of severe problem behaviors in intellectual disability and a case series.
Wachtel LE; Hagopian LP
Isr J Psychiatry Relat Sci; 2006; 43(4):265-74. PubMed ID: 17338446
[TBL] [Abstract][Full Text] [Related]
9. Mentoring treatment teams to integrate behavioral and psychopharmacological treatments in developmental disabilities.
Singh NN; Wahler RG; Sabaawi M; Goza AB; Singh SD; Molina EJ; Winton AS; Strand PS; Hill OW; Singh J; Barber JW; El-Sabaawi M; Dumas J;
Res Dev Disabil; 2002; 23(6):379-89. PubMed ID: 12426007
[TBL] [Abstract][Full Text] [Related]
10. Treatment of psychiatric morbidity in the mentally retarded adult.
Lund J
Acta Psychiatr Scand; 1986 Apr; 73(4):429-36. PubMed ID: 2873716
[TBL] [Abstract][Full Text] [Related]
11. Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes.
Spreat S; Conroy J
Psychiatr Serv; 1998 Apr; 49(4):510-2. PubMed ID: 9550242
[TBL] [Abstract][Full Text] [Related]
12. [Sultopride therapy of behavior disorders in a child with severe mental retardation].
Samouelian J
Ann Pediatr (Paris); 1985 Mar; 32(3 Pt 2):321-2. PubMed ID: 4004042
[No Abstract] [Full Text] [Related]
13. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
Madrid AL; State MW; King BH
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
[TBL] [Abstract][Full Text] [Related]
14. Cognitive-behavioral therapy. Treating individuals with dual diagnoses.
Romana MS
J Psychosoc Nurs Ment Health Serv; 2003 Dec; 41(12):30-5. PubMed ID: 14682029
[TBL] [Abstract][Full Text] [Related]
15. Soles of the Feet: a mindfulness-based self-control intervention for aggression by an individual with mild mental retardation and mental illness.
Singh NN; Wahler RG; Adkins AD; Myers RE;
Res Dev Disabil; 2003; 24(3):158-69. PubMed ID: 12742385
[TBL] [Abstract][Full Text] [Related]
16. Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions.
Matson JL; Bielecki J; Mayville SB; Matson ML
Res Dev Disabil; 2003; 24(3):149-57. PubMed ID: 12742384
[TBL] [Abstract][Full Text] [Related]
17. Problem behavior and psychiatric impairment within a developmentally disabled population. III: Psychotropic medication.
Jacobson JW
Res Dev Disabil; 1988; 9(1):23-38. PubMed ID: 3353539
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and pharmacotherapy of extremely disruptive behavior disorders in people with mental retardation].
Tanaka K; Aita C; Hirano M
No To Hattatsu; 2006 Jan; 38(1):19-24. PubMed ID: 16447792
[TBL] [Abstract][Full Text] [Related]
19. [Mental health among mentally disabled persons].
Skullerud E; Linaker OM; Svenning AC; Torske H
Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3246-8. PubMed ID: 11187162
[TBL] [Abstract][Full Text] [Related]
20. Psychotropic medication use in children and adolescents in an inpatient setting.
Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
